Lithia Motors Inc
Change company Symbol lookup
Select an option...
LAD Lithia Motors Inc
BIOAF Bioasis Technologies Inc
NRGOF Newrange Gold Corp
ADERW 26 Capital Acquisition Equity Warrant Exp 31 Dec 2027 *W EXP 12/31/2027
CMI Cummins Inc
OTLY Oatly Group AB
SNLAF Sino Land Co Ltd
UE Urban Edge Properties
BRLIU Brilliant Acquisition Corp
CXDC China XD Plastics Company Ltd
Go

Consumer Discretionary : Specialty Retail | Small Cap Value
Company profile

Lithia Motors, Inc. is a provider of personal transportation solutions in the United States. It operates in three segments: Domestic, Import and Luxury. The Domestic segment comprises retail automotive franchises that sell new vehicles manufactured by Stellantis, General Motors and Ford. The Import segment is comprised of retail automotive franchises that sell new vehicles manufactured primarily by Toyota, Honda, Hyundai, Subaru, Nissan, and Volkswagen. Its Luxury segment is comprised of retail automotive franchises that sell new vehicles manufactured primarily by BMW, Mercedes, and Lexus. The franchises in each segment also sell used vehicles, parts and automotive services, as well as automotive finance and insurance products. It offers vehicle ownership lifecycle, including new and used vehicles, and financing. It also owns Ferrari store, which specializes in personalized, in-home customer experiences. In addition to Ferrari, this store also sells Bentley and other luxury brands.

Closing Price
$284.14
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
292.21
Day's Low
283.56
Volume
(Below Average)
Volume:
255,468

10-day average volume:
314,674
255,468

Amarin to Present at Jefferies London Healthcare Conference

8:00 am ET November 9, 2022 (Globe Newswire) Print
Amarin to Present at Jefferies London Healthcare ConferenceGlobeNewswireNovember 09, 2022

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin's president and chief executive officer, is scheduled to participate at the Jefferies London Healthcare Conference.

Jefferies London Healthcare Conference (November 15-17th, 2022; London)

Date/Time:November 16, 2022, 9:40 a.m. ET/ 2:40 p.m. GMT+1
Webcast:https://wsw.com/webcast/jeff255/amrn/1851714

The presentation will be webcast live and archived on the Company's website in the Investor Relations section under Events and Presentations at Events | Amarin Corporation plc.

About Amarin

Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in scientific research to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.

Availability of Other Information About Amarin

Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin's investor relations website and may include social media channels. The contents of Amarin's website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Amarin Contact Information

Investor Inquiries:

Investor Relations

Amarin Corporation plc

IR@amarincorp.com (investor inquiries)

Media Inquiries:

Communications

Amarin Corporation plc

PR@amarincorp.com (media inquiries)



Primary Logo

comtex tracking

COMTEX_418472055/2010/2022-11-09T08:00:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.